MBX · MBX Biosciences, Inc.
$60.28
+0.14 (+0.23%)
At close · Jul 21
Market Cap
$2.87B
Shares
47.60M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$87M
-40.5%
FY2025
Diluted EPS
-$2.38
+59.1%
FY2025
Operating Cash Flow
-$79.95M
-46.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $75.23M | $79.16M | $57.42M | $28.53M | |
| $23.56M | $18.9M | $10.78M | $6.78M | |
| $98.79M | $98.06M | $68.19M | $35.31M | |
| -$98.79M | -$98.06M | -$68.19M | -$35.31M | |
| — | -$87M | -$61.9M | — | |
| — | $0 | $0 | $0 | |
| -$86.64M | -$87M | -$61.92M | -$32.56M | |
| -$86.61M | -$86.97M | -$61.92M | -$32.56M | |
| -$87.27M | -$86.74M | -$61.93M | -$32.51M | |
| USD/shares | — | -$2.38 | -$5.82 | -$31.96 |
| USD/shares | — | -$2.38 | -$5.82 | -$31.96 |
| shares | — | 36.51M | 10.64M | 1.02M |
| shares | — | 36.51M | 10.64M | 1.02M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.68×
EV/EBIT
—
Biotechnology median 26.45×
P/E (TTM)
—
Biotechnology median 7.21×
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1776111
CUSIP
55287L101
13F (30d)
12 filings
12 filers
Visit website
Investor relations